Xenobiotic metabolism in brain.

[1]  M. Boyd,et al.  Flavin-containing monooxygenase mediated metabolism of psychoactive drugs by human brain microsomes , 1995, Brain Research.

[2]  J R Cashman,et al.  The mammalian flavin-containing monooxygenases: molecular characterization and regulation of expression. , 1994, Toxicology and applied pharmacology.

[3]  G. Siest,et al.  Localization of Drug‐Metabolizing Enzyme Activities to Blood‐Brain Interfaces and Circumventricular Organs , 1994, Journal of neurochemistry.

[4]  J. Gustafsson,et al.  Effect of ethanol on cytochrome P450 in the rat brain. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[5]  S. Nelson,et al.  The role of metabolic activation in drug toxicity. , 1994, Drug metabolism reviews.

[6]  J. Miller,et al.  Research in chemical carcinogenesis with Elizabeth Miller--a trail of discovery with our associates. , 1994, Drug metabolism reviews.

[7]  H. Strobel,et al.  Identification of cytochromes P450 1A2, 2A1, 2C7, 2E1 in rat glioma C6 cell line by RT-PCR and specific restriction enzyme digestion. , 1993, Biochemical and biophysical research communications.

[8]  J. Gustafsson,et al.  Role of brain cytochrome P450 in regulation of the level of anesthetic steroids in the brain. , 1993, Molecular pharmacology.

[9]  C. J. Omiecinski,et al.  Regional distribution and expression modulation of cytochrome P-450 and epoxide hydrolase mRNAs in the rat brain. , 1993, Molecular pharmacology.

[10]  M. Komori.  A novel P450 expressed at the high level in rat brain. , 1993, Biochemical and biophysical research communications.

[11]  K. Tipton,et al.  Advances in Our Understanding of the Mechanisms of the Neurotoxicity of MPTP and Related Compounds , 1993, Journal of neurochemistry.

[12]  C. J. Omiecinski,et al.  Regiospecific expression of cytochrome P-450s and microsomal epoxide hydrolase in human brain tissue. , 1993, Journal of toxicology and environmental health.

[13]  D. Williams,et al.  Cerebral flavin-containing monooxygenase-mediated metabolism of antidepressants in brain: immunochemical properties and immunocytochemical localization. , 1993, The Journal of pharmacology and experimental therapeutics.

[14]  J. Williams,et al.  Differential effect of chronic nicotine administration on brain cytochrome P4501A1/2 and P4502E1. , 1993, Biochemical and biophysical research communications.

[15]  R. Vijayalakshmi,et al.  Rat brain flavin-containing monooxygenase: catalytic activity and sex-related difference , 1993 .

[16]  P. Zaphiropoulos,et al.  Identification of the major cytochrome P450s of subfamily 2C that are expressed in brain of female rats and in olfactory lobes of ethanol treated male rats. , 1993, Biochemical and biophysical research communications.

[17]  J. Williams,et al.  The Chronic Administration of Nicotine Induces Cytochrome P450 in Rat Brain , 1993, Journal of neurochemistry.

[18]  M. Boyd,et al.  Purification of multiple forms of cytochrome P450 from a human brain and reconstitution of catalytic activities. , 1993, Archives of Biochemistry and Biophysics.

[19]  G. Siest,et al.  Subcellular localization of cytochrome P450, and activities of several enzymes responsible for drug metabolism in the human brain. , 1993, Biochemical pharmacology.

[20]  M. Boyd,et al.  Induction of brain cytochrome P-450IIE1 by chronic ethanol treatmen , 1993, Brain Research.

[21]  M. J. Coon,et al.  The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. , 1993, DNA and cell biology.

[22]  M. Boyd,et al.  Characterization of a phenobarbital-inducible cytochrome P-450, NADPH-cytochrome P-450 reductase and reconstituted cytochrome P-450 mono-oxygenase system from rat brain. Evidence for constitutive presence in rat and human brain. , 1992, The Biochemical journal.

[23]  P. Thomas,et al.  Brain cytochrome P450 and testosterone metabolism by rat brain subcellular fractions: presence of cytochrome P450 3A immunoreactive protein in rat brain mitochondria. , 1992, Archives of biochemistry and biophysics.

[24]  S. Shankar,et al.  Microsomal cytochrome P450 in human brain regions. , 1992, Biochemical pharmacology.

[25]  I. Paul,et al.  Differential effects of cytochrome P-450 induction on ligand binding to σ receptors , 1992 .

[26]  H. Strobel,et al.  Reconstitution of the Brain Mixed Function Oxidase System: Purification of NADPH‐Cytochrome P450 Reductase and Partial Purification of Cytochrome P450 from Whole Rat Brain , 1992, Journal of neurochemistry.

[27]  B. Summers,et al.  Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease , 1992, The Lancet.

[28]  W. Lichtensteiger,et al.  Asymmetry of brain aromatase activity: region- and sex-specific developmental patterns. , 1992, Neuroendocrinology.

[29]  J. Cashman,et al.  Molecular cloning of the flavin-containing monooxygenase (form II) cDNA from adult human liver. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Falck,et al.  Brain Synthesis and Cerebrovascular Action of Epoxygenase Metabolites of Arachidonic Acid , 1992, Journal of neurochemistry.

[31]  G. Siest,et al.  Chapter 49: Drug metabolizing enzymes in the rat pituitary gland , 1992 .

[32]  L. Sultatos,et al.  Biotransformation of the insecticide parathion by mouse brain. , 1992, Toxicology letters.

[33]  P. Hall.  Cytochrome P-450 C21scc: One enzyme with two actions: Hydroxylase and lyase , 1991, The Journal of Steroid Biochemistry and Molecular Biology.

[34]  F. Oesch,et al.  Mapping of phenytoin-inducible cytochrome P450 immunoreactivity in the mouse central nervous system , 1991, Neuroscience.

[35]  J. Langston,et al.  Biotransformation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in primary cultures of mouse astrocytes. , 1991, The Journal of pharmacology and experimental therapeutics.

[36]  S. Povey,et al.  Cloning, primary sequence, and chromosomal mapping of a human flavin-containing monooxygenase (FMO1). , 1991, The Journal of biological chemistry.

[37]  V. Ravindranath,et al.  Presence of flavin-containing monooxygenase in rat brain. , 1991, Biochemical pharmacology.

[38]  R. Tyndale,et al.  Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): potent inhibition of activity by (-)-cocaine and nucleotide sequence identity to human hepatic P450 gene CYP2D6. , 1991, Molecular pharmacology.

[39]  V. Ravindranath,et al.  Administration of testosterone alleviates the constitutive sex difference in rat brain cytochrome P-450 , 1991, Neuroscience Letters.

[40]  K. Reuhl,et al.  Cellular and regional distribution of reduced glutathione in the nervous system of the rat: histochemical localization by mercury orange and o-phthaldialdehyde-induced histofluorescence. , 1991, Toxicology and applied pharmacology.

[41]  N. Salem,et al.  Lipoxygenation in rat brain? , 1991, Biochemical and biophysical research communications.

[42]  J. Musacchio,et al.  SKF 525-A and cytochrome P-450 ligands inhibit with high affinity the binding of [3H]dextromethorphan and sigma ligands to guinea pig brain. , 1991, Life sciences.

[43]  M. Ingelman-Sundberg,et al.  Regional distribution of ethanol-inducible cytochrome P450 IIE1 in the rat central nervous system , 1990, Neuroscience.

[44]  S. Shankar,et al.  Rat brain cytochromes P-450: catalytic, immunochemical properties and inducibility of multiple forms , 1990, Brain Research.

[45]  G. Siest,et al.  Distribution of cytochrome P450 activities towards alkoxyresorufin derivatives in rat brain regions, subcellular fractions and isolated cerebral microvessels. , 1990, Biochemical pharmacology.

[46]  P. Seth,et al.  Cytochrome P-450 dependent monooxygenases in neuronal and glial cells: inducibility and specificity. , 1990, Biochemical and biophysical research communications.

[47]  S. Ross.  Is the sigma opiate receptor a proadifen-sensitive subform of cytochrome P-450? , 1990, Pharmacology & toxicology.

[48]  G. Snyder,et al.  Role of arachidonic acid or its metabolites in growth-hormone-releasing factor-induced release of somatostatin from the median eminence. , 1990, Neuroendocrinology.

[49]  B. Weiss,et al.  Regional and subcellular distribution of cytochrome P-450-dependent drug metabolism in monkey brain: the olfactory bulb and the mitochondrial fraction have high levels of activity. , 1990, Biochemical and biophysical research communications.

[50]  V. Ravindranath,et al.  Preparation of brain microsomes with cytochrome P450 activity using calcium aggregation method. , 1990, Analytical biochemistry.

[51]  S. Shankar,et al.  NADPH cytochrome P-450 reductase in rat, mouse and human brain. , 1990, Biochemical pharmacology.

[52]  R. Tyndale,et al.  The dopamine transporter and cytochrome P45OIID1 (debrisoquine 4-hydroxylase) in brain: resolution and identification of two distinct [3H]GBR-12935 binding proteins. , 1990, Archives of biochemistry and biophysics.

[53]  S. Shankar,et al.  Xenobiotic metabolism in human brain — presence of cytochrome P-450 and associated mono-oxygenases , 1989, Brain Research.

[54]  V. Ravindranath,et al.  High activity of cytochrome P-450-linked aminopyrine N-demethylase in mouse brain microsomes, and associated sex-related difference. , 1989, The Biochemical journal.

[55]  V. Ravindranath,et al.  Low glutathione levels in brain regions of aged rats , 1989, Neuroscience Letters.

[56]  C. Kasper,et al.  Quantitation of mRNAs specific for the mixed-function oxidase system in rat liver and extrahepatic tissues during development. , 1989, Archives of biochemistry and biophysics.

[57]  H. Strobel,et al.  Brain cytochromes P-450 are responsive to phenobarbital and tricyclic amines. , 1989, Pharmacological research.

[58]  M. Maines,et al.  Manganese-mediated increase in the rat brain mitochondrial cytochrome P-450 and drug metabolism activity: susceptibility of the striatum. , 1989, The Journal of pharmacology and experimental therapeutics.

[59]  J. Gustafsson,et al.  Regional Distribution of Cytochrome P‐450 in the Rat Brain: Spectral Quantitation and Contribution of P‐450b,e and P‐450c,d , 1988, Journal of neurochemistry.

[60]  F. Oesch,et al.  First evidence of cytochrome P-450 induction in the mouse brain by phenytoin , 1988, Neuroscience Letters.

[61]  C. Köhler,et al.  Immunohistochemical localization of cytochrome P-450 in the rat brain , 1988, Neuroscience Letters.

[62]  O. Sugita,et al.  Aromatization and 19-hydroxylation of androgens by rat brain cytochrome P-450. , 1988, Biochemical and biophysical research communications.

[63]  G. Siest,et al.  A new aspect of the protective functions of the blood-brain barrier: activities of four drug-metabolizing enzymes in isolated rat brain microvessels. , 1988, Life sciences.

[64]  J. Gustafsson,et al.  Cytochrome P-450 b and c in the rat brain and pituitary gland. , 1988, Molecular pharmacology.

[65]  D. Ziegler,et al.  Flavin-containing monooxygenases: catalytic mechanism and substrate specificities. , 1988, Drug metabolism reviews.

[66]  E. Baulieu,et al.  Neurosteroids: oligodendrocyte mitochondria convert cholesterol to pregnenolone. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[67]  U. Meyer,et al.  MPTP, the neurotoxin inducing Parkinson's disease, is a potent competitive inhibitor of human and rat cytochrome P450 isozymes (P450bufI, P450db1) catalyzing debrisoquine 4-hydroxylation. , 1987, Biochemical and biophysical research communications.

[68]  O. Sugita,et al.  Partial purification of cytochrome P450 from rat brain and demonstration of estradiol hydroxylation. , 1987, Biochemical and biophysical research communications.

[69]  M. Waterman,et al.  Neurosteroids: cytochrome P-450scc in rat brain. , 1987, Science.

[70]  G. Siest,et al.  Quantitative measurement of cerebral cytochrome P-450 by second derivative spectrophotometry , 1987, Journal of Neuroscience Methods.

[71]  G. Siest,et al.  Brain mitochondrial cytochrome P-450scc: spectral and catalytic properties. , 1987, Archives of biochemistry and biophysics.

[72]  G. Siest,et al.  Ethoxyresorufin O-deethylase activity in rat brain subcellular fractions , 1987, Neuroscience Letters.

[73]  D. Jacobowitz,et al.  Immunohistochemical localization of cytochrome P-450 in rat brain , 1987, Neuroscience.

[74]  F. Gonzalez,et al.  Complementary DNA and protein sequences of ethanol-inducible rat and human cytochrome P-450s. Transcriptional and post-transcriptional regulation of the rat enzyme. , 1986, The Journal of biological chemistry.

[75]  A. Eisen,et al.  ALZHEIMER'S DISEASE, PARKINSON'S DISEASE, AND MOTONEURONE DISEASE: ABIOTROPIC INTERACTION BETWEEN AGEING AND ENVIRONMENT? , 1986, The Lancet.

[76]  G. Siest,et al.  Subcellular distribution of cytochrome P-450 in the brain , 1986, Brain Research.

[77]  S. Paul,et al.  Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. , 1986, Science.

[78]  M. Ames,et al.  Metabolic activation of the serotonergic neurotoxin para-chloroamphetamine to chemically reactive intermediates by hepatic and brain microsomal preparations. , 1986, Biochemical pharmacology.

[79]  D. Williams,et al.  Rabbit lung flavin-containing monooxygenase. Purification, characterization, and induction during pregnancy. , 1985, Molecular pharmacology.

[80]  E. Hodgson,et al.  Catalytic activity and substrate specificity of the flavin-containing monooxygenase in microsomal systems: characterization of the hepatic, pulmonary and renal enzymes of the mouse, rabbit, and rat. , 1985, Archives of biochemistry and biophysics.

[81]  E. Hodgson,et al.  Identification of distinct hepatic and pulmonary forms of microsomal flavin-containing monooxygenase in the mouse and rabbit. , 1985, Biochemical and biophysical research communications.

[82]  D. Liebler,et al.  Enzymatic activation of chemicals to toxic metabolites. , 1985, Critical reviews in toxicology.

[83]  D. Williams,et al.  Rabbit lung flavin-containing monooxygenase is immunochemically and catalytically distinct from the liver enzyme. , 1984, Biochemical and biophysical research communications.

[84]  M. Duffel,et al.  Microsomal Flavin‐Containing Monooxygenase Activity in Rat Corpus Striatum , 1984, Journal of neurochemistry.

[85]  J. Gustafsson,et al.  Presence of NADPH-cytochrome P450 reductase in central catecholaminergic neurones , 1984, Nature.

[86]  D. Jacobowitz,et al.  A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[87]  M. Notelovitz,et al.  Mestranol-induced hypertension: characterization of cytochrome P-450 dependent catechol estrogen formation in brain microsomes. , 1983, Biochemical pharmacology.

[88]  A. Torvik,et al.  Brain lesions in alcoholics A neuropathological study with clinical correlations , 1982, Journal of the Neurological Sciences.

[89]  T. Nabeshima,et al.  Effects of chronic administration of pentobarbital or morphine on the brain microsomal cytochrome P-450 system. , 1981, Biochemical pharmacology.

[90]  H. Mukhtar,et al.  Characterization of microsomal aryl hydrocarbon hydroxylase of rat brain. , 1981, The Journal of pharmacology and experimental therapeutics.

[91]  M. R. Boyd,et al.  Biochemical mechanisms in chemical-induced lung injury: roles of metabolic activation. , 1980, Critical reviews in toxicology.

[92]  J. Monti,et al.  Metabolism of the hallucinogen N,N-dimethyltryptamine in rat brain homogenates. , 1980, Biochemical pharmacology.

[93]  D. Ziegler.  Chapter 9 – Microsomal Flavin-Containing Monooxygenase: Oxygenation of Nucleophilic Nitrogen and Sulfur Compounds , 1980 .

[94]  Sanford P. Markey,et al.  Chronic parkinsonism secondary to intravenous injection of meperidine analogues , 1979, Psychiatry Research.

[95]  F. Guengerich,et al.  Immunological comparison of hepatic and extrahepatic cytochromes P-450. , 1979, Molecular pharmacology.

[96]  E. Miller.  Some current perspectives on chemical carcinogenesis in humans and experimental animals: Presidential Address. , 1978, Cancer research.

[97]  M. Hedden,et al.  Behavioral effects and metabolic fate of N,N-dimethyltryptamine in mice pretreated with β-diethylaminoethyl-diphenylpropylacetate (SKF 525-A), iproniazid and chlorpromazine , 1978, Pharmacology Biochemistry and Behavior.

[98]  S. Paul,et al.  Catechol estrogen-forming enzyme of brain: demonstration of a cytochrome p450 monooxygenase. , 1977, Endocrinology.

[99]  M. Boyd.  Evidence for the Clara cell as a site of cytochrome P450-dependent mixed-function oxidase activity in lung , 1977, Nature.

[100]  M. Ames,et al.  Cytochrome P-450 and NADPH cytochrome c reductase in rat brain: formation of catechols and reactive catechol metabolites. , 1977, Biochemical and biophysical research communications.

[101]  A. Kappas,et al.  On the occurrence of cytochrome P-450 and aryl hydrocarbon hydroxylase activity in rat brain , 1977, The Journal of experimental medicine.

[102]  E. Domino,et al.  Effects of iproniazid and tranylcypromine of the half-life of N,N-dimethyltryptamine in rat brain and liver. , 1976, Biochemical pharmacology.

[103]  J. Fishman,et al.  N-demethylation of morphine in rat brain is localised in sites with high opiate receptor content , 1976, Nature.

[104]  B. Brodie,et al.  Biochemical Mechanisms of Drug Toxicity , 1974 .

[105]  H. Weissbach,et al.  Studies on the mechanism of action of monoamine oxidase: metabolism of N,N-dimethyltryptamine and N,N-dimethyltryptamine-N-oxide. , 1962, Biochemistry.

[106]  B. Howes,et al.  The oxidative deamination of serotonin and other 3-(beta-aminoethyl)-indoles by monamine oxidase and the effect of these compounds on the deamination of tyramine. , 1953, Science.